JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE)
JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE)
Recruiting · NCT06675422 · Registry updated 2024-11-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE) | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Phase 1 / Phase 2 | 2024-11-05 | NCT06675422 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| 920th HJointLogistics | Kunming | China | 3 |